Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion type Assertion NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_head.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion wasGeneratedBy ECO_0000203 NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion wasDerivedFrom befree-20140225 NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion SIO_000772 23658459 NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion evidence source_evidence_literature NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion description "[We evaluated whether dovitinib (TKI258), an inhibitor of FGFR1, FGFR2, and FGFR3, presented antitumor activity in FGFR-amplified breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.